DIADEMA PARTNERS LP
An institutional investment manager in MORRISTOWN, NJ. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 14, 2026. SEC CIK 2026172.
- Reported value$791.3m
- Positions149
Holdings: 149 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Viking Therapeutics IncVKTX | COM | 92686J106 | 47.6 | 6.0% | 1,220,800 | Call | Added+561,600 |
| Abivax SAABVX | SPONSORED ADS | 00370M103 | 46.5 | 5.9% | 349,200 | Call | Added+249,200 |
| Bristol-Myers Squibb CoBMY | COM | 110122108 | 34.6 | 4.4% | 600,000 | Call | New+600,000 |
| Abivax SAABVX | SPONSORED ADS | 00370M103 | 33.6 | 4.3% | 252,400 | Put | Added+152,400 |
| United Therapeutics Corp DelUTHR | COM | 91307C102 | 28.7 | 3.6% | 52,989 | Added+25,686 | |
| Revolution Medicines IncRVMD | COM | 76155X100 | 26.1 | 3.3% | 139,218 | Added+58,346 | |
| Abivax SAABVX | SPONSORED ADS | 00370M103 | 21.6 | 2.7% | 163,644 | Added+87,700 | |
| Cogent Biosciences IncCOGT | COM | 19240Q201 | 19.1 | 2.4% | 493,664 | Added+170,900 | |
| Bristol-Myers Squibb CoBMY | COM | 110122108 | 19.0 | 2.4% | 330,600 | Put | New+330,600 |
| Bridgebio Pharma Inc | NOTE 1.750% 3/0 | 10806XAJ1 | 18.6 | 2.4% | $250,000 principal | New+250,000 | |
| Corcept Therapeutics IncCORT | COM | 218352102 | 17.9 | 2.3% | 206,300 | Call | Added+47,800 |
| Biomarin Pharmaceutical IncBMRN | COM | 09061G101 | 17.9 | 2.3% | 312,846 | Added+164,617 | |
| Viking Therapeutics IncVKTX | COM | 92686J106 | 17.2 | 2.2% | 441,808 | Reduced−83,373 | |
| Kymera Therapeutics IncKYMR | COM | 501575104 | 17.2 | 2.2% | 149,700 | Call | New+149,700 |
| Novartis AGNVS | SPONSORED ADR | 66987V109 | 15.7 | 2.0% | 100,000 | Put | New+100,000 |
| Uniqure NV | SHS | N90064101 | 13.8 | 1.7% | 299,000 | Put | Unchanged |
| Viking Therapeutics IncVKTX | COM | 92686J106 | 13.7 | 1.7% | 350,500 | Put | New+350,500 |
| Biogen IncBIIB | COM | 09062X103 | 13.0 | 1.6% | 60,000 | Call | New+60,000 |
| Capricor Therapeutics IncCAPR | COM NEW | 14070B309 | 12.9 | 1.6% | 534,400 | Put | Reduced−89,000 |
| Summit Therapeutics IncSMMT | COM | 86627T108 | 12.5 | 1.6% | 860,200 | Call | New+860,200 |
| ELI Lilly & CoLLY | COM | 532457108 | 12.0 | 1.5% | 10,000 | Put | New+10,000 |
| Incyte CorpINCY | COM | 45337C102 | 11.9 | 1.5% | 105,400 | Put | Unchanged |
| Edgewise Therapeutics IncEWTX | COM | 28036F105 | 11.1 | 1.4% | 272,214 | New+272,214 | |
| Uniqure NV | SHS | N90064101 | 10.8 | 1.4% | 235,400 | Call | Reduced−14,600 |
| Biontech SEBNTX | SPONSORED ADS | 09075V102 | 9.3 | 1.2% | 100,000 | Call | New+100,000 |
| Kodiak Sciences IncKOD | COM | 50015M109 | 8.5 | 1.1% | 218,117 | Added+25,155 | |
| Immunocore Holdings plcIMCR | ADS | 45258D105 | 8.1 | 1.0% | 254,863 | Added+61,674 | |
| Capricor Therapeutics IncCAPR | COM NEW | 14070B309 | 7.9 | 1.0% | 329,300 | Call | Unchanged |
| Novartis AGNVS | SPONSORED ADR | 66987V109 | 7.8 | 1.0% | 50,000 | Call | New+50,000 |
| Replimune Group IncREPL | COM | 76029N106 | 7.7 | 1.0% | 696,300 | Call | Added+490,800 |
| Kodiak Sciences IncKOD | COM | 50015M109 | 7.7 | 1.0% | 196,700 | Call | Added+196,500 |
| 4D Molecular Therapeutics inFDMT | COM | 35104E100 | 7.6 | 1.0% | 571,107 | New+571,107 | |
| Moderna IncMRNA | COM | 60770K107 | 7.0 | 0.9% | 100,000 | Put | Reduced−59,400 |
| Hims & Hers Health IncHIMS | COM CL A | 433000106 | 6.9 | 0.9% | 200,000 | Call | New+200,000 |
| Arcus Biosciences IncRCUS | COM | 03969F109 | 6.9 | 0.9% | 223,810 | Reduced−14,332 | |
| Hims & Hers Health IncHIMS | COM CL A | 433000106 | 6.7 | 0.8% | 193,700 | Put | New+193,700 |
| Corbus Pharmaceuticals HoldingsCRBP | COM NEW | 21833P301 | 5.9 | 0.8% | 633,800 | Call | Added+518,500 |
| Sellas Life Sciences Group ISLS | COM NEW | 81642T209 | 5.9 | 0.7% | 400,000 | Call | Added+100,000 |
| Kodiak Sciences IncKOD | COM | 50015M109 | 5.7 | 0.7% | 146,900 | Put | Reduced−100,000 |
| Alumis IncALMS | COM | 022307102 | 5.6 | 0.7% | 200,000 | Call | Added+100,000 |
| Royalty Pharma plc | SHS CLASS A | G7709Q104 | 5.6 | 0.7% | 100,000 | Call | New+100,000 |
| Johnson & JohnsonJNJ | COM | 478160104 | 5.6 | 0.7% | 22,000 | Reduced−31,771 | |
| Replimune Group IncREPL | COM | 76029N106 | 5.6 | 0.7% | 502,500 | Put | Added+42,600 |
| Bioage Labs IncBIOA | COM | 09077V100 | 4.9 | 0.6% | 200,100 | Call | New+200,100 |
| Novo-Nordisk a SNVO | ADR | 670100205 | 4.8 | 0.6% | 100,000 | Added+85,423 | |
| Biohaven Ltd | COM | G1110E107 | 4.7 | 0.6% | 317,000 | Call | Unchanged |
| Tenax Therapeutics IncTENX | COM NEW | 88032L605 | 4.5 | 0.6% | 307,000 | Call | New+307,000 |
| Corvus Pharmaceuticals IncCRVS | COM | 221015100 | 4.4 | 0.6% | 294,811 | Added+50,000 | |
| Relay Therapeutics IncRLAY | COM | 75943R102 | 4.3 | 0.5% | 230,677 | New+230,677 | |
| TG Therapeutics IncTGTX | COM | 88322Q108 | 4.2 | 0.5% | 75,700 | Call | New+75,700 |
| Monte Rosa Therapeutics IncGLUE | COM | 61225M102 | 4.1 | 0.5% | 170,100 | Call | New+170,100 |
| Arcus Biosciences IncRCUS | COM | 03969F109 | 3.8 | 0.5% | 124,000 | Call | New+124,000 |
| Unicycive Therapeutics IncUNCY | COM NEW | 90466Y202 | 3.7 | 0.5% | 792,600 | Call | New+792,600 |
| Zymeworks IncZYME | COM | 98985Y108 | 3.7 | 0.5% | 142,132 | Unchanged | |
| Amgen IncAMGN | COM | 031162100 | 3.6 | 0.5% | 10,000 | Call | New+10,000 |
| Bioage Labs IncBIOA | COM | 09077V100 | 3.6 | 0.5% | 146,334 | Added+86,334 | |
| Taysha Gene Therapies IncTSHA | COM SHS | 877619106 | 3.6 | 0.4% | 522,619 | New+522,619 | |
| Intellia Therapeutics IncNTLA | COM | 45826J105 | 3.4 | 0.4% | 200,000 | Call | Unchanged |
| Celldex Therapeutics Inc NewCLDX | COM NEW | 15117B202 | 3.2 | 0.4% | 86,000 | Put | New+86,000 |
| Vaxcyte IncPCVX | COM | 92243G108 | 3.1 | 0.4% | 53,100 | Call | Unchanged |
| Nurix Therapeutics IncNRIX | COM | 67080M103 | 2.9 | 0.4% | 121,539 | New+121,539 | |
| Summit Therapeutics IncSMMT | COM | 86627T108 | 2.9 | 0.4% | 200,000 | Put | New+200,000 |
| Vaxcyte IncPCVX | COM | 92243G108 | 2.8 | 0.4% | 48,900 | Put | New+48,900 |
| Corbus Pharmaceuticals HoldingsCRBP | COM NEW | 21833P301 | 2.8 | 0.4% | 301,264 | Reduced−138,693 | |
| Indivior Pharmaceuticals IncINDV | COM | 45579U109 | 2.8 | 0.4% | 67,512 | Reduced−3,864 | |
| Inventiva SAIVA | ADS | 46124U107 | 2.7 | 0.3% | 740,786 | Added+388,387 | |
| Novo-Nordisk a SNVO | ADR | 670100205 | 2.7 | 0.3% | 55,900 | Put | Unchanged |
| Oruka Therapeutics IncORKA | COM | 687604108 | 2.6 | 0.3% | 27,799 | New+27,799 | |
| Vaxcyte IncPCVX | COM | 92243G108 | 2.6 | 0.3% | 45,071 | Added+20,000 | |
| Cytokinetics IncCYTK | COM NEW | 23282W605 | 2.6 | 0.3% | 30,000 | Put | Reduced−170,000 |
| Relmada Therapeutics IncRLMD | COM | 75955J402 | 2.5 | 0.3% | 361,367 | Added+160,525 | |
| Vera Therapeutics IncVERA | CL A | 92337R101 | 2.5 | 0.3% | 57,608 | New+57,608 | |
| Vera Therapeutics IncVERA | CL A | 92337R101 | 2.1 | 0.3% | 50,000 | Put | New+50,000 |
| Celcuity IncCELC | COM | 15102K100 | 2.1 | 0.3% | 20,000 | Call | Added+2,300 |
| Annexon IncANNX | COM | 03589W102 | 2.0 | 0.3% | 353,200 | Call | Unchanged |
| Septerna IncSEPN | COM | 81734D104 | 2.0 | 0.3% | 59,700 | Put | New+59,700 |
| Corvus Pharmaceuticals IncCRVS | COM | 221015100 | 2.0 | 0.3% | 133,400 | Call | Added+27,100 |
| Contineum Therapeutics IncCTNM | CL A | 21217B100 | 2.0 | 0.2% | 119,733 | New+119,733 | |
| Bicycle Therapeutics plcBCYC | SPONSORED ADS | 088786108 | 2.0 | 0.2% | 462,724 | Reduced−13,700 | |
| Monte Rosa Therapeutics IncGLUE | COM | 61225M102 | 1.9 | 0.2% | 78,391 | Reduced−108,916 | |
| Celldex Therapeutics Inc NewCLDX | COM NEW | 15117B202 | 1.9 | 0.2% | 50,900 | Call | New+50,900 |
| Viridian Therapeutics IncVRDN | COM | 92790C104 | 1.8 | 0.2% | 100,000 | New+100,000 | |
| Macrogenics IncMGNX | COM | 556099109 | 1.7 | 0.2% | 374,403 | Reduced−225,597 | |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | 1.7 | 0.2% | 926,016 | Added+745,933 | |
| Adma Biologics IncADMA | COM | 000899104 | 1.7 | 0.2% | 200,000 | Call | New+200,000 |
| Spruce Biosciences IncSPRB | COM NEW | 85209E208 | 1.6 | 0.2% | 30,000 | Added+20,000 | |
| Ardelyx IncARDX | COM | 039697107 | 1.5 | 0.2% | 303,025 | New+303,025 | |
| CUE Biopharma IncCUE | COM | 22978P205 | 1.5 | 0.2% | 48,369 | New+48,369 | |
| Mineralys Therapeutics IncMLYS | COM | 603170101 | 1.5 | 0.2% | 56,347 | Added+30,000 | |
| Eyepoint IncEYPT | COM NEW | 30233G209 | 1.5 | 0.2% | 106,300 | Call | Unchanged |
| Sellas Life Sciences Group ISLS | COM NEW | 81642T209 | 1.5 | 0.2% | 100,000 | Put | New+100,000 |
| Prothena Corp plc | SHS | G72800108 | 1.5 | 0.2% | 149,482 | New+149,482 | |
| Voyager Therapeutics IncVYGR | COM | 92915B106 | 1.4 | 0.2% | 413,642 | Reduced−10,000 | |
| Unicycive Therapeutics IncUNCY | COM NEW | 90466Y202 | 1.4 | 0.2% | 303,676 | Added+197,593 | |
| Phathom Pharmaceuticals IncPHAT | COM | 71722W107 | 1.4 | 0.2% | 129,950 | Added+75,300 | |
| Evolus IncEOLS | COM | 30052C107 | 1.4 | 0.2% | 200,000 | Call | Added+74,800 |
| Spyre Therapeutics IncSYRE | COM NEW | 00773J202 | 1.3 | 0.2% | 15,000 | New+15,000 | |
| Cybin Inc | COM NEW | 23256X407 | 1.3 | 0.2% | 200,000 | New+200,000 | |
| Cormedix IncCRMD | COM | 21900C308 | 1.3 | 0.2% | 167,500 | Put | Unchanged |
| Editas Medicine IncEDIT | COM | 28106W103 | 1.3 | 0.2% | 400,000 | Call | New+400,000 |
| Equillium IncEQ | COM | 29446K106 | 1.3 | 0.2% | 400,282 | Reduced−33,562 | |
| Pyxis Oncology IncPYXS | COMMON STOCK | 747324101 | 1.2 | 0.1% | 388,200 | Call | New+388,200 |
| Xeris Biopharma Holdings IncXERS | COM | 98422E103 | 1.1 | 0.1% | 132,746 | Unchanged | |
| Pharvaris N V | COM | N69605108 | 1.0 | 0.1% | 29,321 | Unchanged | |
| Harmony Biosciences Holdings inHRMY | COM | 413197104 | 1.0 | 0.1% | 26,864 | Reduced−66,000 | |
| Cartesian Therapeutics IncRNAC | COM NEW | 816212302 | 0.9 | 0.1% | 87,057 | New+87,057 | |
| Aquestive Therapeutics IncAQST | COM | 03843E104 | 0.9 | 0.1% | 214,600 | Call | New+214,600 |
| Rigel Pharmaceuticals IncRIGL | COM | 766559702 | 0.9 | 0.1% | 22,816 | New+22,816 | |
| Summit Therapeutics IncSMMT | COM | 86627T108 | 0.9 | 0.1% | 60,000 | New+60,000 | |
| Precigen IncPGEN | COM | 74017N105 | 0.8 | <0.1% | 135,293 | Added+80,000 | |
| Definium Therapeutics IncDFTX | COM SHS | 24477V105 | 0.7 | <0.1% | 15,451 | New+15,451 | |
| Pelthos Therapeutics IncPTHS | COM SHS | 171126204 | 0.7 | <0.1% | 24,773 | Unchanged | |
| Pepgen IncPEPG | COM | 713317105 | 0.7 | <0.1% | 373,284 | Added+222,359 | |
| Cybin Inc | COM NEW | 23256X407 | 0.7 | <0.1% | 100,000 | Call | New+100,000 |
| Voyager Therapeutics IncVYGR | COM | 92915B106 | 0.5 | <0.1% | 150,000 | Call | Unchanged |
| CG Oncology IncCGON | COM | 156944100 | 0.5 | <0.1% | 7,300 | Call | New+7,300 |
| Enliven Therapeutics IncELVN | COM | 29337E102 | 0.5 | <0.1% | 10,000 | Added+9,755 | |
| Connect Biopharma Holdings Ltd | SHS | G23549101 | 0.5 | <0.1% | 196,985 | Reduced−3,705 | |
| Larimar Therapeutics IncLRMR | COM | 517125100 | 0.4 | <0.1% | 146,637 | Reduced−20,000 | |
| Elicio Therapeutics IncELTX | COM | 28657F103 | 0.4 | <0.1% | 112,100 | Call | New+112,100 |
| Elicio Therapeutics IncELTX | COM | 28657F103 | 0.4 | <0.1% | 100,000 | Put | New+100,000 |
| Cellectar Biosciences IncCLRB | COM NEW | 15117F880 | 0.4 | <0.1% | 138,341 | New+138,341 | |
| Foghorn Therapeutics IncFHTX | COM | 344174107 | 0.3 | <0.1% | 66,908 | Reduced−13,036 | |
| Aytu Biopharma IncAYTU | COM | 054754858 | 0.3 | <0.1% | 148,546 | Reduced−204,531 | |
| Ocugen IncOCGN | COM | 67577C105 | 0.3 | <0.1% | 200,000 | Unchanged | |
| Inovio Pharmaceuticals IncINO | COM SHS | 45773H409 | 0.3 | <0.1% | 275,200 | Call | Added+200,000 |
| Urogen Pharma Ltd | COM | M96088105 | 0.3 | <0.1% | 7,137 | Reduced−16,018 | |
| Amgen IncAMGN | COM | 031162100 | 0.2 | <0.1% | 102,701 | New+102,701 | |
| Heron Therapeutics IncHRTX | COM | 427746102 | 0.2 | <0.1% | 458,723 | New+458,723 | |
| Talphera IncTLPH | COM NEW | 00444T209 | 0.2 | <0.1% | 153,563 | Unchanged | |
| Annexon IncANNX | COM | 03589W102 | 0.2 | <0.1% | 27,516 | Reduced−105,400 | |
| Monopar Therapeutics IncMNPR | COM NEW | 61023L207 | 0.2 | <0.1% | 1,630 | Unchanged | |
| Lakeland Inds IncLAKE | COM | 511795106 | 0.2 | <0.1% | 14,108 | New+14,108 | |
| Upstream Bio IncUPB | COM | 91678A107 | 0.1 | <0.1% | 19,093 | Reduced−2,516 | |
| Meiragtx Holdings plc | COM | G59665102 | 0.1 | <0.1% | 8,368 | New+8,368 | |
| Jatt II Acquisition Corp | ORD SHS | G50765109 | 0.1 | <0.1% | 9,021 | New+9,021 | |
| Kailera Therapeutics IncKLRA | COMMON STOCK | 482931102 | 0.1 | <0.1% | 3,621 | New+3,621 | |
| Mannkind CorpMNKD | COM NEW | 56400P706 | 0.1 | <0.1% | 16,003 | Reduced−170,600 | |
| Entera Bio Ltd | SHS | M40527109 | 0.0 | <0.1% | 23,260 | Unchanged | |
| ARS Pharmaceuticals IncSPRY | COM | 82835W108 | 0.0 | <0.1% | 4,860 | New+4,860 | |
| Aprea Therapeutics IncAPRE | COM NEW | 03836J201 | 0.0 | <0.1% | 44,907 | New+44,907 | |
| Tvardi Therapeutics IncTVRD | COM | 140755307 | 0.0 | <0.1% | 16,607 | New+16,607 | |
| Vistagen Therapeutics IncVTGN | COM | 92840H400 | 0.0 | <0.1% | 57,700 | Call | New+57,700 |
| Nextcure IncNXTC | COM NEW | 65343E207 | 0.0 | <0.1% | 7,742 | New+7,742 | |
| Atyr Pharma IncATYR | COM NEW | 002120202 | 0.0 | <0.1% | 12,500 | Put | Unchanged |
| Meiragtx Holdings plc | COM | G59665102 | 0.0 | <0.1% | 500 | Call | New+500 |
| Jade Biosciences IncJBIO | COM NEW | 008064206 | 0.0 | <0.1% | 1,046 | Put | Unchanged |
| Erasca IncERAS | COM | 29479A108 | 0.0 | <0.1% | 100 | Call | New+100 |
| CUE Biopharma IncCUE | COM | 22978P205 | 0.0 | <0.1% | 6 | Call | New+6 |
Sold out: 64 positions
Held at the end of the quarter before and not reported this quarter.
| Issuer | Class | CUSIP | Reported value$ | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Abbvie IncABBV | COM | 00287Y109 | 0.0 | 0.0% | 0 | Sold out−24,058 | |
| Alkermes plc | SHS | G01767105 | 0.0 | 0.0% | 0 | Sold out−50,000 | |
| Alumis IncALMS | COM | 022307102 | 0.0 | 0.0% | 0 | Put | Sold out−31,200 |
| Anavex Life Sciences CorpAVXL | COM NEW | 032797300 | 0.0 | 0.0% | 0 | Call | Sold out−477,600 |
| Apogee Therapeutics Inc | COM | 03770N101 | 0.0 | 0.0% | 0 | Call | Sold out−222,500 |
| Atrium Therapeutics IncRNA | COM | 04965N104 | 0.0 | 0.0% | 0 | Sold out−2,512 | |
| Atyr Pharma IncATYR | COM NEW | 002120202 | 0.0 | 0.0% | 0 | Call | Sold out−12,200 |
| Bridgebio Pharma IncBBIO | COM | 10806X102 | 0.0 | 0.0% | 0 | Sold out−85,311 | |
| Bridgebio Pharma Inc | NOTE 1.750% 3/0 | 10806XAJ1 | 0.0 | 0.0% | 0 | Sold out−250,000 | |
| Capricor Therapeutics IncCAPR | COM NEW | 14070B309 | 0.0 | 0.0% | 0 | Sold out−78,851 | |
| Celcuity IncCELC | COM | 15102K100 | 0.0 | 0.0% | 0 | Sold out−5,314 | |
| Climb Bio IncCLYM | COM | 28658R106 | 0.0 | 0.0% | 0 | Sold out−286,126 | |
| Compass Pathways plcCMPS | SPONSORED ADS | 20451W101 | 0.0 | 0.0% | 0 | Sold out−31,885 | |
| Corcept Therapeutics IncCORT | COM | 218352102 | 0.0 | 0.0% | 0 | Sold out−10,000 | |
| Crispr Therapeutics AG | NAMEN AKT | H17182108 | 0.0 | 0.0% | 0 | Call | Sold out−106,300 |
| CUE Biopharma Inc | COM | 22978P106 | 0.0 | 0.0% | 0 | Sold out−131,997 | |
| Cytokinetics IncCYTK | COM NEW | 23282W605 | 0.0 | 0.0% | 0 | Call | Sold out−50,000 |
| Cytomx Therapeutics Inc.CTMX | COM | 23284F105 | 0.0 | 0.0% | 0 | Call | Sold out−316,000 |
| Dianthus Therapeutics IncDNTH | COM | 252828108 | 0.0 | 0.0% | 0 | Sold out−10,000 | |
| Edgewise Therapeutics IncEWTX | COM | 28036F105 | 0.0 | 0.0% | 0 | Call | Sold out−212,500 |
| ELI Lilly & CoLLY | COM | 532457108 | 0.0 | 0.0% | 0 | Sold out−6,000 | |
| Enanta Pharmaceuticals IncENTA | COM | 29251M106 | 0.0 | 0.0% | 0 | Sold out−64,952 | |
| Eupraxia Pharmaceuticals IncEPRX | COM | 29842P105 | 0.0 | 0.0% | 0 | Sold out−40,000 | |
| Eyepoint IncEYPT | COM NEW | 30233G209 | 0.0 | 0.0% | 0 | Sold out−178,545 | |
| GH Research plc | ORDINARY SHARES | G3855L106 | 0.0 | 0.0% | 0 | Sold out−26,836 | |
| Immunitybio IncIBRX | COM | 45256X103 | 0.0 | 0.0% | 0 | Put | Sold out−106,300 |
| Incyte CorpINCY | COM | 45337C102 | 0.0 | 0.0% | 0 | Sold out−78,029 | |
| Inovio Pharmaceuticals IncINO | COM SHS | 45773H409 | 0.0 | 0.0% | 0 | Sold out−562,665 | |
| Iovance Biotherapeutics IncIOVA | COM | 462260100 | 0.0 | 0.0% | 0 | Call | Sold out−300,000 |
| Iovance Biotherapeutics IncIOVA | COM | 462260100 | 0.0 | 0.0% | 0 | Put | Sold out−2,900 |
| Janux Therapeutics IncJANX | COM | 47103J105 | 0.0 | 0.0% | 0 | Call | Sold out−31,600 |
| Jazz Pharmaceuticals plc | SHS USD | G50871105 | 0.0 | 0.0% | 0 | Sold out−54,755 | |
| Karyopharm Therapeutics IncKPTI | COM NEW | 48576U205 | 0.0 | 0.0% | 0 | Call | Sold out−241,300 |
| Lipocine Inc NewLPCN | COM NEW | 53630X203 | 0.0 | 0.0% | 0 | Sold out−50,000 | |
| Liquidia CorporationLQDA | COM NEW | 53635D202 | 0.0 | 0.0% | 0 | Call | Sold out−662,100 |
| Liquidia CorporationLQDA | COM NEW | 53635D202 | 0.0 | 0.0% | 0 | Put | Sold out−50,000 |
| Lyell Immunopharma IncLYEL | COM NEW | 55083R203 | 0.0 | 0.0% | 0 | Put | Sold out−4,100 |
| Maze Therapeutics IncMAZE | COM | 578784100 | 0.0 | 0.0% | 0 | Sold out−15,000 | |
| Merck & Co IncMRK | COM | 58933Y105 | 0.0 | 0.0% | 0 | Put | Sold out−100,000 |
| Ocugen IncOCGN | COM | 67577C105 | 0.0 | 0.0% | 0 | Call | Sold out−300,000 |
| Olema Pharmaceuticals IncOLMA | COM | 68062P106 | 0.0 | 0.0% | 0 | Call | Sold out−84,000 |
| Passage Bio IncPASG | COM NEW | 702712209 | 0.0 | 0.0% | 0 | Sold out−19,530 | |
| Puretech Health plcPTCHF | ADS | 746237106 | 0.0 | 0.0% | 0 | Sold out−7,924 | |
| Replimune Group IncREPL | COM | 76029N106 | 0.0 | 0.0% | 0 | Sold out−100,660 | |
| Revolution Medicines IncRVMD | COM | 76155X100 | 0.0 | 0.0% | 0 | Put | Sold out−125,500 |
| Rocket Pharmaceuticals IncRCKT | COM | 77313F106 | 0.0 | 0.0% | 0 | Sold out−30,579 | |
| Roivant Sciences Ltd | SHS | G76279101 | 0.0 | 0.0% | 0 | Put | Sold out−335,800 |
| Septerna IncSEPN | COM | 81734D104 | 0.0 | 0.0% | 0 | Sold out−202 | |
| Shattuck Labs IncSTTK | COM | 82024L103 | 0.0 | 0.0% | 0 | Sold out−293,664 | |
| Structure Therapeutics IncGPCR | SPONSORED ADS | 86366E106 | 0.0 | 0.0% | 0 | Put | Sold out−127,500 |
| Structure Therapeutics IncGPCR | SPONSORED ADS | 86366E106 | 0.0 | 0.0% | 0 | Sold out−72,234 | |
| Tarsus Pharmaceuticals IncTARS | COM | 87650L103 | 0.0 | 0.0% | 0 | Sold out−25,942 | |
| Tenax Therapeutics IncTENX | COM NEW | 88032L605 | 0.0 | 0.0% | 0 | Sold out−179,738 | |
| Terns Pharmaceuticals Inc | COM | 880881107 | 0.0 | 0.0% | 0 | Sold out−181,752 | |
| TG Therapeutics IncTGTX | COM | 88322Q108 | 0.0 | 0.0% | 0 | Sold out−206,928 | |
| Trevi Therapeutics IncTRVI | COM | 89532M101 | 0.0 | 0.0% | 0 | Sold out−21,663 | |
| Ultragenyx Pharmaceutical inRARE | COM | 90400D108 | 0.0 | 0.0% | 0 | Sold out−35,144 | |
| Uniqure NV | SHS | N90064101 | 0.0 | 0.0% | 0 | Sold out−31,200 | |
| United Therapeutics Corp DelUTHR | COM | 91307C102 | 0.0 | 0.0% | 0 | Put | Sold out−20,000 |
| United Therapeutics Corp DelUTHR | COM | 91307C102 | 0.0 | 0.0% | 0 | Call | Sold out−40,200 |
| Vertex Pharmaceuticals IncVRTX | COM | 92532F100 | 0.0 | 0.0% | 0 | Call | Sold out−93,100 |
| Vertex Pharmaceuticals IncVRTX | COM | 92532F100 | 0.0 | 0.0% | 0 | Sold out−3,840 | |
| VIR Biotechnology IncVIR | COM | 92764N102 | 0.0 | 0.0% | 0 | Call | Sold out−88,800 |
| Vistagen Therapeutics IncVTGN | COM | 92840H400 | 0.0 | 0.0% | 0 | Sold out−105,428 |
Source: SEC EDGAR, Form 13F-HR, accession 0001892688-26-000119 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.